RANDOMIZED STUDY OF PEMETREXED PLUS CARBOPLATIN FOLLOWED BY PEMETREXED VERSUS PACLITAXEL PLUS CARBOPLATIN FOLLOWED BY PEMETREXED IN NON-SQUAMOUS NSCLC (LOGIK0904)

被引：0
|
作者：
Moriwaki, Atsushi [1 ,10 ]
Inoue, Koji [2 ,10 ]
Takeshita, Masafumi [2 ,10 ]
Harada, Taishi [3 ,10 ]
Tashiro, Naoki [4 ,10 ]
Seto, Takashi [5 ,10 ]
Imanaga, Tomotoshi [1 ,10 ]
Fujimoto, Noriko [6 ,10 ]
Nakagaki, Noriaki [7 ,10 ]
Kawasaki, Masayuki [8 ,10 ]
Kishimoto, Junji [9 ,10 ]
Takayama, Koichi [3 ,10 ]
Ichinose, Yukito [5 ,10 ]
机构：
[1] Steel Mem Yawata Hosp, Dept Resp Dis, Kitakyushu, Fukuoka, Japan
[2] Kitakyushu Municipal Med Ctr, Dept Resp Med, Kitakyushu, Fukuoka, Japan
[3] Kyushu Univ, Res Inst Dis Chest, Grad Sch Med Sci, Fukuoka 812, Japan
[4] Fukuoka Univ, Sch Med, Dept Resp Med, Fukuoka 81401, Japan
[5] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan
[6] St Marys Hosp, Dept Resp Dis, Fukuoka, Japan
[7] Natl Hosp Org Fukuoka Higashi Med Ctr, Dept Resp Dis, Fukuoka, Japan
[8] Natl Hosp Org Omuta Hosp, Dept Resp Med, Fukuoka, Japan
[9] Kyushu Univ Hosp, Ctr Clin & Translat Res, Fukuoka 812, Japan
[10] Lung Oncol Grp Kyushu, Fukuoka, Japan
来源：
RESPIROLOGY | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [1] RANDOMIZED PHASE II STUDY OF PEMETREXED PLUS CARBOPLATIN FOLLOWED BY PEMETREXED VERSUS PACLITAXEL PLUS CARBOPLATIN FOLLOWED BY PEMETREXED IN ADVANCED NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (LOGIK 0904)
    Shiraishi, Yoshimasa
    Inoue, Koji
    Takeshita, Masafumi
    Harada, Taishi
    Tashiro, Naoki
    Seto, Takashi
    Imanaga, Tomotoshi
    Fujimoto, Noriko
    Nakagaki, Noriaki
    Kawasaki, Masayuki
    Kishimoto, Junji
    Takayama, Koichi
    Ichinose, Yukito
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S403 - S404
  • [2] Randomized phase II study of pemetrexed plus carboplatin followed by pemetrexed versus paclitaxel plus carboplatin followed by pemetrexed in advanced nonsquamous, non-small cell lung cancer (LOGIK 0904)
    Takayama, Koichi
    Inoue, Koji
    Takeshita, Masafumi
    Tashiro, Naoki
    Harada, Taishi
    Seto, Takashi
    Imanaga, Tomotoshi
    Fujimoto, Noriko
    Nakagaki, Noriaki
    Kawasaki, Masayuki
    Kishimoto, Junji
    Ichinose, Yukito
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] A Phase II Study of Pemetrexed plus Carboplatin Followed by Maintenance Pemetrexed in Elderly Patients with Advanced Non-Squamous NSCLC
    Tamiya, Motohiro
    Tamiya, Akihiro
    Kaneda, Hiroyasu
    Nakagawa, Kazuhiko
    Goto, Koichi
    Yoh, Kiyotaka
    Okamoto, Hiroaki
    Shimokawa, Tsuneo
    Tanaka, Hiroshi
    Abe, Tetsuya
    Daga, Haruko
    Takeda, Koji
    Hirashima, Tomonori
    Atagi, Shinji
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S316 - S316
  • [4] Pemetrexed-Carboplatin Versus Paclitaxel (Weekly)-Carboplatin as First Line Chemotherapy in Advanced Non-Squamous NSCLC
    Malik, P.
    Yadav, A.
    Jain, D.
    Pathy, S.
    Mohan, A.
    Khurana, S.
    Kumar, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S354 - S355
  • [5] Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer
    Yokoi, Takashi
    Torii, Yoshitaro
    Katashiba, Yuichi
    Sugimoto, Hiroyuki
    Tanijiri, Tsutomu
    Ogata, Makoto
    Inagaki, Noriko
    Kibata, Kayoko
    Hayashi, Mina
    Niki, Maiko
    Shimizu, Toshiki
    Miyara, Takayuki
    Kurata, Takayasu
    Nomura, Shosaku
    [J]. ONCOLOGY LETTERS, 2014, 8 (06) : 2453 - 2457
  • [6] Induction Pemetrexed and Cisplatin Followed by Maintenance Pemetrexed Versus Carboplatin Plus Paclitaxel Plus Bevacizumab Followed by Maintenance Bevacizumab: A Quality of Life-Oriented Randomized Phase III Study in Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer (ERACLE)
    Galetta, Domenico
    Pisconti, Salvatore
    Cinieri, Saverio
    Pappagallo, Giovanni Luigi
    Gebbia, Vittorio
    Borsellino, Nicola
    Maiello, Evaristo
    Rinaldi, Antonio
    Montrone, Michele
    Rizzo, Pietro
    Marzano, Nicola
    Sasso, Nicola
    Febbraro, Antonio
    Colucci, Giuseppe
    [J]. CLINICAL LUNG CANCER, 2011, 12 (06) : 402 - 406
  • [7] PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer
    Patel, Jyoti D.
    Socinski, Mark A.
    Garon, Edward B.
    Reynolds, Craig H.
    Spigel, David R.
    Olsen, Mark R.
    Hermann, Robert C.
    Jotte, Robert M.
    Beck, Thaddeus
    Richards, Donald A.
    Guba, Susan C.
    Liu, Jingyi
    Frimodt-Moller, Bente
    John, William J.
    Obasaju, Coleman K.
    Pennella, Eduardo J.
    Bonomi, Philip
    Govindan, Ramaswamy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4349 - U77
  • [8] Randomized, open-label, phase III study of pemetrexed plus carboplatin followed by maintenance pemetrexed (Arm A) versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab (Arm B) in patients with advanced nonsquamous (NS) non-small cell lung cancer (NSCLC).
    Zinner, Ralph
    Ross, Helen J.
    Weaver, Robert
    Govindan, Ramaswamy
    Holden, Viran R.
    Chowhan, Naveed Mahfooz
    Beck, J. Thaddeus
    Waterhouse, David Michael
    Modiano, Manuel
    Rao, Vijay Phooshkooru
    Liu, Jingyi
    Koustenis, Andrew
    Melemed, Symantha
    Guba, Susan C.
    Ortuzar, Waldo Feliu
    Desaiah, Durisala
    Spigel, David R.
    Obasaju, Coleman K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Randomized, open-label, phase III study of pemetrexed plus carboplatin (PemC) followed by maintenance pemetrexed versus paclitaxel/carboplatin/bevacizumab (PCB) followed by maintenance bevacizumab in patients with advanced nonsquamous (NS) non-small cell lung cancer (NSCLC).
    Zinner, Ralph
    Ross, Helen J.
    Weaver, Robert
    Govindan, Ramaswamy
    Holden, Viran R.
    Chowhan, Naveed Mahfooz
    Beck, J. Thaddeus
    Waterhouse, David Michael
    Modiano, Manuel
    Rao, Vijay Phooshkooru
    Liu, Jingyi
    Koustenis, Andrew
    Melemed, Symantha
    Guba, Susan C.
    Ortuzar, Waldo Feliu
    Desaiah, Durisala
    Spigel, David R.
    Obasaju, Coleman K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (18)
  • [10] Phase II study of carboplatin/pemetrexed/bevacizumab followed by bev/erlotinib maintenance for non-squamous NSCLC with WT EGFR
    Watanabe, Masahiro
    Takashina, Taichi
    Asahina, Hajime
    Amano, Toraji
    Yokouchi, Hiroshi
    Takamura, Kei
    Harada, Toshiyuki
    Honjo, Osamu
    Morikawa, Naoto
    Kinoshita, Ichiro
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 91 - 92
12345